Phase 3 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already taken part in the related Phase III trial (NCT05115942), completed the full treatment course, and attended the final visit.
- You must be willing to take part voluntarily, be able to communicate well with the research team, follow all study requirements, and sign a consent form showing you understand what the trial involves, including its possible benefits and risks.
Who may not be able to join:
- You experienced one of certain serious health events during the Phase III trial — for example, developing cirrhosis, liver cancer, serious liver complications (such as fluid build-up in the abdomen, internal bleeding, a type of kidney failure, brain problems caused by liver disease, or blood clots in the liver's main vein), a liver transplant, or death related to liver disease (confirm with trial site for the full list relevant to your situation).
- You have been diagnosed with a cancer other than liver cancer, and doctors expect you to live less than one year.
- The trial team has any concern that taking part could affect your safety, affect the trial results, or that something may make it difficult for you to give proper consent or follow the trial's requirements (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lungen Lu, Dr, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phone: +86-13501209210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cumulative incidence of clinical endpoint events (defined as the occurrence of any clinical endpoint event).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.